TY  - RPRT
TI  - DNA methylation is a key determinant of response to targeted and immune checkpoint therapies in metastatic renal cell carcinoma
AU  - Jeanneret, F.
AU  - Schoch, S.
AU  - Ballester, P.
AU  - Symeonides, S. N.
AU  - Laird, A.
AU  - Axelson, H.
AU  - Pflieger, D.
AU  - Battail, C.
PY  - 2024
DO  - 10.1101/2024.11.05.622095
UR  - https://www.biorxiv.org/content/10.1101/2024.11.05.622095v1
ID  - 10.1101/2024.11.05.622095
ER  -